Work

Abstract A048: PRC2 inhibition enhances KRAS inhibitor response to delay treatment relapse in KRAS-mutant preclinical lung and colorectal cancer models

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a048

Authors: Stephanie W. Ni, Natalie Yuen, Livia Ulicna, Denise F. Reyes, Michal Pawlak, Frank L. Duong, Jason E. Long, Aleksandr Pankov, Lori S. Friedman, Anneleen Daemen, Melissa R. Junttila

Institution: ORIC Pharmaceuticals, Inc. (United States)

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444503

Cites:

Cited by:

Related to: